**Background:** Cashmere, a keratinized product of secondary hair follicles (SHFs) in cashmere goats, is a high-value textile. The molecular mechanisms underlying hair follicle (HF) development, particularly the role of non-coding RNAs (ncRNAs), are poorly understood. This study aimed to systematically investigate a competing endogenous RNA (ceRNA) regulatory network involving circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) during SHF development in cashmere goat embryos, focusing on the interaction between miR-184 and fibroblast growth factor 10 (FGF10).
**Methods:** Skin samples were collected from Inner Mongolian cashmere goat fetuses at embryonic days 75 (E75) and 125 (E125), representing early and late stages of HF development. Whole-transcriptome sequencing (long RNA-seq and small RNA-seq) was performed on six samples (three per time point). After quality control, sequence alignment, and differential expression analysis (p < 0.05, fold change ≥ 2), differentially expressed mRNAs, circRNAs, and miRNAs were identified. A ceRNA network was constructed using Cytoscape. The targeting relationship between miR-184 and FGF10 was validated via dual-luciferase reporter assays in 293T and GFF cells. Secondary HF dermal papilla cells (SHF-DPCs) were transfected with miR-184 mimics/inhibitors or FGF10 overexpression/siRNA vectors. Cell proliferation was assessed using CCK-8 at 12, 24, 36, and 48 h. Apoptosis was detected by Annexin V-FITC/PI staining and flow cytometry at 48 h. Cell cycle analysis was performed using PI staining and flow cytometry at 48 h. FGF10 expression was measured by RT-qPCR and Western blotting.
**Key Results:** Sequencing yielded 813,141,270 raw reads from long RNA-seq and 91,915,124 from small RNA-seq, with clean read percentages >99% and >96%, respectively. A total of 6468 differentially expressed mRNAs (3234 upregulated, 3234 downregulated), 394 differentially expressed circRNAs (154 upregulated, 240 downregulated), and 239 differentially expressed miRNAs (97 upregulated, 142 downregulated) were identified between E75 and E125. The ceRNA network included 5581 ncRNA relationship pairs, covering 219 miRNAs, 2477 mRNAs, and 232 circRNAs. Dual-luciferase assays confirmed that miR-184 binds to the 3'UTR of FGF10 and to chi-circRNA-0001141. In SHF-DPCs, miR-184 overexpression significantly reduced FGF10 mRNA and protein levels (p < 0.01 and p < 0.001, respectively), while miR-184 interference increased them (p < 0.01 and p < 0.001). FGF10 overexpression promoted cell proliferation (OD higher at 36 h, p < 0.01; 48 h, p < 0.05) and inhibited apoptosis (apoptosis rate lower, p < 0.05), while FGF10 knockdown had opposite effects (proliferation lower at 36 and 48 h, p < 0.01; apoptosis higher, p < 0.01). miR-184 overexpression inhibited proliferation (OD lower at 36 h, p < 0.05; 48 h, p < 0.01) and promoted apoptosis (apoptosis rate higher, p < 0.01), while miR-184 interference promoted proliferation (OD higher at 36 h, p < 0.001; 48 h, p < 0.05) and inhibited apoptosis (apoptosis rate lower, p < 0.001). Cell cycle analysis showed that FGF10 overexpression decreased G0/G1 phase (p < 0.001) and increased S phase (p < 0.001), while FGF10 knockdown increased G0/G1 (p < 0.05) and decreased S phase (p < 0.05). miR-184 overexpression increased G0/G1 (p < 0.05) and decreased S phase (p < 0.01), while miR-184 interference decreased G0/G1 (p < 0.01) and increased S phase (p < 0.05) and G2/M phase (p < 0.05).
**Clinical Implications:** This study elucidates a novel ceRNA regulatory mechanism involving miR-184 and FGF10 in cashmere goat SHF development. The findings suggest that miR-184 acts as a negative regulator of SHF-DPC proliferation and survival by targeting FGF10, while FGF10 promotes proliferation and inhibits apoptosis. This knowledge provides a theoretical foundation for genetic breeding strategies to improve cashmere yield and quality. Additionally, the identified ceRNA network may offer insights into hair follicle biology in other mammals, potentially informing treatments for hair loss disorders. However, the study is limited by its focus on in vitro cell experiments and lack of in vivo validation, and the role of chi-circRNA-0001141 requires further investigation.